Post-marketing Safety Surveillance of Compound Kuh-seng Injection: a Registry Study

• Status: Completed
• Trial end date: 2018-10-01
• Target enrollment: 0
• Participant gender: All

Summary

This registry aims to monitor the safety of Compound Kuh-seng Injection and to identify the potential risk factors for the adverse drug reactions. Compound Kuh-seng Injection is a kind of natural compound injection extracted from herbs Kuh-seng (Radix Sophorae Flavescentis) and Rhizoma Heterosmilacis Japonicae.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Zhong Wang
• Collaborator: Shanxi Zhendong pharmaceutical Co. LTD.

Criteria

Inclusion Criteria:

• Patients who use Compound Kushen Injection in the monitoring hospitals

Exclusion Criteria:

• None